Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody respon...
Guardado en:
Autores principales: | Marion Avril, Marianne J Hathaway, Anand Srivastava, Sébastien Dechavanne, Mirja Hommel, James G Beeson, Joseph D Smith, Benoît Gamain |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34488d96197a41ceb3b5616c494c6798 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Var2CSA minimal CSA binding region is located within the N-terminal region.
por: Anand Srivastava, et al.
Publicado: (2011) -
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Jonathan P. Renn, et al.
Publicado: (2021) -
Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade
por: Jaymin C. Patel, et al.
Publicado: (2017) -
An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.
por: Borko Amulic, et al.
Publicado: (2009) -
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
por: Vera V Pinto, et al.
Publicado: (2011)